INNOVAX®-ILT

For the vaccination of 18-day-old chicken embryos by in ovo administration and of healthy 1-day-old chickens by subcutaneous route as an aid in the prevention of Marek’s disease (MD) and infectious laryngotracheitis (ILT).

PRODUCT LABEL

Diseases/Parasites

Indications

Innovax-ILT is recommended for vaccination of healthy 18-day-old chicken embryos by the in ovo route or 1-day-old chickens by subcutaneous injection as an aid in the prevention of Marek’s disease and infectious laryngotracheitis.

Advantages

  • Provides protection against both MD and ILT1
  • Aids in prevention of ILT through at least 60 weeks of age1
  • Offers flexibility for vaccination schedules by offering in ovo as well as subcutaneous administration1
  • Eliminates respiratory vaccination reactions caused by chickens vaccinated with live conventional ILT vaccines1
  • Eliminates an increase in vaccination reactions from other respiratory vaccines1
  • Eliminates latency, persistence, and spread caused by chickens vaccinated with live conventional ILT vaccines1
  • Prevents vaccine induced ILT outbreaks1

Supplied

2,000 dose ampules

For additional information, please see the product label.

References:

  1. Data on file, Merck Animal Health.